Skip to main content
. 2016 Jun 28;15:91. doi: 10.1186/s12933-016-0411-8

Table 1.

Clinical and biochemical characteristics of type 2 diabetes relatives (R) and control subjects (C)

Relatives (R)
n = 23
Controls (C)
n = 24
p value
Sex (m/f) 12/11 13/11 n.s.
Age (years) 46.8 (12.0) 47.2 (11.7) n.s.
BMI (kg/m2) 25.1 (3.8) 25.0 (3.1) n.s.
Weight (kg) 78.4 (16.4) 77.5 (15.1) n.s
Waist (cm) 88.6 (12.0) 88.2 (11.5) n.s.
Waist/hip ratio 0.86 (0.09) 0.85 (0.09) n.s.
Heart rate at rest (beats/min) 65.7 (8.1) 66.3 (7.5) n.s.
Systolic blood pressure (mmHg) 118 (18) 113 (11) n.s.
Diastolic blood pressure (mmHg) 77 (12) 79 (13) n.s.
Smokers/non-smokers 1/22 3/24 n.s.
Fat mass (%) 28.2 (7.2) 28.8 (7.3) n.s.
Visceral adipose tissue (VAT, cm2)a,b 94.1 (56.4) 101.5 (56.2) n.s.
Subcutaneous adipose tissue (SAT, cm2)a,b 204.4 (75.0) 220.0 (83.1) n.s.
Visceral/subcutaneous adipose tissue ratioa,b 0.48 (0.28) 0.49 (0.28) n.s.
Liver fat content (Mean HU) 66.0 (6.4) 64.2 (5.9) n.s.
HbA1c (IFCC; mmol/mol)c 34.1 (4.0) 33.7 (8.0) n.s.
Fasting blood glucose (mmol/L) 5.5 (0.6) 5.5 (0.5) n.s.
Fasting serum insulin (mU/L) 7.5 (6.9) 6.9 (3.6) n.s.
HOMA IR 1.8 (11.7) 1.7 (50.9) n.s.
HOMA β % 81.0 (69.5) 80.1 (41.2) n.s.
OGTT 2 h blood glucose (mmol/L) 7.3 (1.3) 6.5 (1.3) 0.049
Serum cholesterol (mmol/L) 5.1 (0.9) 5.2 (0.9) n.s.
Serum HDL-cholesterol (mmol/L) 1.36 (0.38) 1.50 (0.43) n.s.
Serum LDL-cholesterol (mmol/L) 3.2 (0.9) 3.2 (0.8) n.s.
Serum triglycerides (mmol/L) 1.21 (0.73) 1.07 (0.39) n.s.
M value (mg/kg lean body mass/min) 12.4 (5.0) 13.2 (4.5) n.s.
Mean serum insulin during clamp (mU/L) 92.9 (31.4) 94.6 (22.0) n.s.
Insulin sensitivity index (ISI) [(100 × mg/kg/(mU/L)] 15.0 (7.2) 15.0 (7.0) n.s
Plasma NEFA (µmol/L)
 Basal 0.28 (0.10) 0.33 (0.11) 0.09
 During clamp 0.03 (0.05) 0.02 (0.01) n.s.

Data are means (sd) or number of subjects

HU hounsfield units

aOnly subjects participating in the CT examination (n = 44; 21 R. 23 C)

bCalculated values obtained from the CT scans at the L2 and L4 levels

cCalculated values from Mono S